Cadaveric Renal Transplantation: A Single-Center Experience

Renal transplantation remains the treatment of choice for end-stage renal
disease (ESRD) in regard to patient survival. Iran was one of the first countries in the
Middle East that began renal transplantation.
Methods. In a follow-up study, we enrolled all of our cadaveric renal transplant
recipients from 2001 to 2007, namely, 39 cases. Related variables collected through
checklists were entered into SPSS software version 16 and analyzed using the Kaplan-
Meier method and by descriptive statistics.
Results. The mean age of the recipients was 35.18 � 14.27 years. Twenty-one patients
(53.8%) were men. The underlying disease for development of ESRD was diabetes (7
cases, 21.2%), hypertension (24.2%), glomerulopathies (36.4%), polycystic disease (PKD;
2.6%), and 5 (15.2%) were unknown. Four recipients (10.3%) were hospitalized again
because of acute tubular necrosis after transplantation. An acute rejection episode was
diagnosed in 7 (17.9%) graft recipients. Surgical complications after transplantation were
as follows: urinoma, lymphocele, and surgical site leakage (each 1 case). One-year patient
survival rate was 89.7% in this study; 4 recipients died within 1–9 months after
transplantation. Death-censored 1-year graft survival rate was 100%.
Discussion. The survival rate of cadaveric transplant was in an acceptable range